[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

about

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

Item

http://www.wikidata.org/entity/Q53061048

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

@en

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

@nl

type

Item

label

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

@en

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

@nl

prefLabel

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

@en

[Selective internal radioembolization in nonresectable hepatocellular carcinoma].

@nl

P1476

[Selective internal radioembolization in nonresectable hepatocellular carcinoma]

@en

P2093

A Altendorf-Hofmann

http://www.w3.org/2001/XMLSchema#string

A Bauschke

http://www.w3.org/2001/XMLSchema#string

C Malessa

http://www.w3.org/2001/XMLSchema#string

M Freesmeyer

http://www.w3.org/2001/XMLSchema#string

T Winkens

http://www.w3.org/2001/XMLSchema#string

U Settmacher

http://www.w3.org/2001/XMLSchema#string

U Teichgraeber

http://www.w3.org/2001/XMLSchema#string

P2860

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.

Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Radioembolization for primary and metastatic liver cancer.

Hong Kong consensus recommendations on the management of hepatocellular carcinoma.

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.

P2888

s00104-016-0259-1

P304

956-963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00104-016-0259-1

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan-Henning Schierz

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27460230

http://www.w3.org/2001/XMLSchema#string